What Could a New Iron Discovery Mean for Lung Cancer Immunotherapy?
New research published in Nature Cancer has identified iron accumulation as a trigger for the destruction of CAR-T immune cells. We explore what this unexpected finding could mean for the future of lung cancer treatment.
PFAS restrictions and medicines: what is the EU proposing, and how it might affect lung cancer treatment
The EU is consulting on new restrictions on PFAS chemicals, also known as “forever chemicals.” Lung Cancer Europe explains what the proposed regulation involves, why it matters for medicine supply, and how we are engaging with the process.